{"name":"Gastroenterology Services, Ltd.","slug":"gastroenterology-services-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Bowel Preparation","genericName":"Bowel Preparation","slug":"bowel-preparation","indication":"Other","status":"phase_2"},{"name":"Gatorade/Miralax","genericName":"Gatorade/Miralax","slug":"gatorade-miralax","indication":"Bowel preparation prior to colonoscopy or other gastrointestinal procedures","status":"marketed"},{"name":"NuLytely","genericName":"NuLytely","slug":"nulytely","indication":"Bowel preparation prior to colonoscopy","status":"marketed"},{"name":"SUPREP","genericName":"SUPREP","slug":"suprep","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Bowel Preparation","genericName":"Bowel Preparation","slug":"bowel-preparation","phase":"phase_2","mechanism":"Induces osmotic diarrhea and bowel evacuation through various mechanisms including osmotic agents, stimulant laxatives, or volume-based cleansing.","indications":[],"catalyst":""},{"name":"Gatorade/Miralax","genericName":"Gatorade/Miralax","slug":"gatorade-miralax","phase":"marketed","mechanism":"Miralax (polyethylene glycol) draws water into the intestinal lumen to soften stool and promote bowel movements, while Gatorade provides electrolyte and fluid replacement.","indications":["Bowel preparation prior to colonoscopy or other gastrointestinal procedures","Constipation relief"],"catalyst":""},{"name":"NuLytely","genericName":"NuLytely","slug":"nulytely","phase":"marketed","mechanism":"NuLytely is an osmotic laxative solution that draws water into the bowel to promote bowel evacuation.","indications":["Bowel preparation prior to colonoscopy","Bowel preparation prior to barium enema or other gastrointestinal procedures"],"catalyst":""},{"name":"SUPREP","genericName":"SUPREP","slug":"suprep","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxQbFhyQ0FXRHJjYkg2aG1KNS1ocHg0ZWRQRWxfWU44ajZpSXg3YS1aM2oycFM5SURaSzZOd1k3QW5HUmN2bktFX0JrVEg1ZVkyX1BGdGpGUTZPcGNLcC13TXduWkUzTDczdEc5ejBJckQza2h1dFdtYlVMYXdPN0s1TnFJR2NuZExuYmo0bExSNUMzczBuOGdpc3RVRnVxNFlYX2EyYjljaURudURnU0xzYWQyTFBJNVhLbGFTLTM3d3hOZDYyanlXMXd0UUtCVzNDS1NrcTZIYXplU3VZQVg0eElyQlhWY1BRanpMTVNDblo5em1ocUJfSDBZRnJFZV9RV2ktY3hvaG9sb1lZSERKUGcwYUc2RFNnTEluQw?oc=5","date":"2026-03-26","type":"regulatory","source":"businesswire.com","summary":"Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan - businesswire.com","headline":"Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Strom","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNSjVzUUZ0MEg2OVcxWnlpbkQ5c3pZVC1DenE3ZXZzTUgxNHFSVVhMb294NkVkMmpiMU9fNEtyaXhGQU9ROE9EQ2hNWDlfQTFySEtSdjV4LXkwMi0wZ0tfN0l2endvSEJxYWxLajV4cVVMRVJ0bW9MQWtCdUJ0eEo3dXZuNVZBMmF1T0RTQ1EzVlVKUWoxM2c?oc=5","date":"2026-03-16","type":"pipeline","source":"Fortune Business Insights","summary":"Pharmaceuticals Market Size, Share, Industry Analysis, 2034 - Fortune Business Insights","headline":"Pharmaceuticals Market Size, Share, Industry Analysis, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNby16WG45Ujk2VkVZaWR1akp1ckNrbFlvakJNS0RzdjBXV0tYUThMMmV2eXAtbThFNVdkeDA5ZkVkTlktNGdiVDFabVBmUkQ3NTlwU2hzOUFTSktCd1MyaWJJU1U4Q29NS1g1a3ZlRFpGSXFQWlQtM2hDeU5RTTdxRDBsbFQ5RnNm?oc=5","date":"2025-08-26","type":"pipeline","source":"Yahoo Finance","summary":"Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship - Yahoo Finance","headline":"Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPWl9ieV9MUk5JaG1iQkhLLUFNQTBXSlFYZHFHc281ZG1Ock5zSDFFYzZ4dGptWFBEb1lKX3BnYlRSR1pydjZ0UDdhd05nVE9vd0YwVXlKZ2lGeWVuOUdubFJkMWhZOTNKUW5heDdnLVcyVW5Mb1VjQU1meTd2UHU5WEVoZklhOC1jc1BkWTZsM2RkN0NVQjYw?oc=5","date":"2025-05-20","type":"trial","source":"Market Data Forecast","summary":"Asia Pacific Gastrointestinal Drugs Market Size, 2033 - Market Data Forecast","headline":"Asia Pacific Gastrointestinal Drugs Market Size, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNOWFvbFozRnJZRVYteklVWmxrQXpwUUhRYXJyaU8xcGZLVGJpRDRRNGxucFBrZFZMdDlKZnljdkY0X2l4YnNVWG0tUHZIZFh3blJVaWNmaDNVMndzTTFSdEZvaDhnVl9tVk0yZkJfazg0aHp5NGdYbkFWQXMtSGRKSURSZ0tfSVN3cFpTYlRrblRBanpxcE9Qc0NzMDJPUG5lMmU5VXN6czBwdVZpb3BKdGc5Q0tYYkhXT3JhWVhn?oc=5","date":"2025-04-29","type":"deal","source":"businesswire.com","summary":"Microba Delivers Landmark IBD Results & Signs Major Gastro Partner - businesswire.com","headline":"Microba Delivers Landmark IBD Results & Signs Major Gastro Partner","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxNbG9yVlRBLVVjVnBGYzRuZ25pVW8tNXBjd3FxTW1UcUMzMHpxRHh3eER2S3FnTVhQNXYxV25MNHYzQk1PekMxVEtKZ3ZwbHpBSGdYTHJjaDJIVUlpNzV0WEFhc0lvd0FVUTh0aFhBdm94YVJNQzhiX2kwM05YdlQycW5zbFd6MFdQWXozRkpPQ0NXMVRLVHJhUlp4ME1FT3RWWGtqTGhvWVIydUNqeU5xQnlXYjBWQ1pUUHRJbHl3YkE0VDdCSnc1Sm0wcFlVSGZlMGF1R19TMDZkMzY2UXlVeG9OU0Q2XzFhaDQ1SFU0d0RfQ3NtTUJURk5YMTVSanpub2Q0R2dfWGRhbDlydW9SWlF1clVEZw?oc=5","date":"2024-12-16","type":"earnings","source":"GlobeNewswire","summary":"Gastroenterology Market is expected to reach a revenue of - GlobeNewswire","headline":"Gastroenterology Market is expected to reach a revenue of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFA2VFdOTm1QV3VhUGlmc1k0OXJtTkh1N0lKVk9VQ1RvTERHVXMxLUZ6Z2NXZDJHOGI4aXV6R2hoQzBsNXYxa0FOX1UycFZZb3RGTzdTMV93UW9ubWJ4bTNV?oc=5","date":"2024-09-16","type":"pipeline","source":"Nature","summary":"Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors - Nature","headline":"Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOcTJub1VvSjRyLXB5VkhEaE05ZVlwQ1lqTWpybXVyRWtrLVNmbUJkSUR4VkJxeUtoczBZX09SVE5Ha2F0V2JpWWdnS3hjWkduOThianpsbUtqSjNWMHdkY3dfcEIzbFZCVjZvNURQS3NoYWRBNko5cktDUlRmeFVlby11aUtxVGpPTVIxVzM4ZHV6b183WW5GTEhsWG11aERiVWdvalVZVQ?oc=5","date":"2024-05-15","type":"pipeline","source":"Gastroenterology Advisor","summary":"Advances in Crohn Disease: Key Updates From the ACG 2023 Annual Meeting - Gastroenterology Advisor","headline":"Advances in Crohn Disease: Key Updates From the ACG 2023 Annual Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQSG45Mkwyai10UnJ0aDcwbnQ1Y0F3dzROZjdYemU0Slk2MGh3TFZoRGhwbFNxU0piY3hpM3BtbnY1QzBwbThweFdIb2NjZzRPMVhUcTZHWU1URGxnVDlZeHZ3X3Y5TkZRTU9tRmd3TjIxLUJHSHc3ZUttY1YtS2xNZGdYT1BJVGZmRUMwTzVudTZ2WWtRWTB2d252NW0yOUtl?oc=5","date":"2022-02-02","type":"pipeline","source":"Pharmacy Times","summary":"Akhil Ravi Appointed CEO of Aurigene Pharmaceutical Services Ltd - Pharmacy Times","headline":"Akhil Ravi Appointed CEO of Aurigene Pharmaceutical Services Ltd","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxQSlU0dXVQeGxRYm5TemFNbUltQlR0Tl9xNU1WblZST2ZnMUVYVndIazdfMWYwck9WdVh3eFUyQUxnMjFHN3FGN3U2T2ZCSURmeHZOdnVpQm55ZjY4QmpUbjNiVVFZbGRZUWVCYWFpMHNNRjdxd1RGSW1NWGdialJtM2t1UHVaR2ozY1ZQS1ZnVnFRclphR3EwNzl3UDRqU3g3N3g2enNJdEVYaTdtbE5HRGhEeW5lM0RSNndOZmVRSTl4QWpwdm1fZlUyal9YTW5GSnVNYlRsdVFaNkQ5ZjBqckVKQ2VtQlNwS1FGMkJjb3pwVHZDdTNmaW1Oal8wakRIbWxwdEFiM28xZ2czUHhKTWhBZnIwLUR5aFVITA?oc=5","date":"2019-11-13","type":"deal","source":"prnewswire.com","summary":"RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Disease Pipeline - prnewswire.com","headline":"RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPTFNCRm5Ed3pIQlJtSHI0WkxxeW5yQnQxSFRMc0VKVGNVNTlKSEhvZjZjQkNaQlRxaUwzMzAwd09EYm9kYWlkSHpkdUxXUmE0Qk9lZzFtUktSUlQ5MzZydmNiTU1DMm85M1UzNkF0V0J0bXZZVnpvUzlZUk1VdVI3clNEelhXYU4yazBsV2c3dTFmX09DRTFsZWo1RTh3ZmhpSjBlLTJlOUUtMzJBMGlOU0piSEFEM1d4bnFfeVBFTGxmMEZ6cVcyQXhzVEtwU0Q5Wmd0andMUzh4T09FZ2lYSjRISlpkbmpmamVR?oc=5","date":"2019-10-04","type":"pipeline","source":"European Medical Journal","summary":"Key Considerations in the Management of Inflammatory Bowel Disease: Interviews with Key Opinion Leaders - European Medical Journal","headline":"Key Considerations in the Management of Inflammatory Bowel Disease: Interviews with Key Opinion Leaders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOaGNJbjhNdUFDTEEzdUZ6Q19YNUx0c1d3RThua3ByTU0zWUs2Z1BIR0RXc3NQaUlZWV92X3ItWkQ0UDBYNWR5ZktXR1JxOGNVdG1FMWoteVp2bW01UEtNYVY5N09oLTZaOW5TcVF6SmpOVjhTallWNTMzM3U4eXo4ZlBQa1JKOVcxQ0ZXSWg1LU42SmZFZFJRUnFuU0pHNkVtaUFGcnh2enFsOEJma1VqdzFBdkUwM0hwekx6WjNBOWo3aG5WTXNF?oc=5","date":"2015-07-09","type":"pipeline","source":"AstraZeneca","summary":"AstraZeneca sharpens focus on main therapy areas through agreement with gastroenterology specialist Tillotts Pharma for Entocort - AstraZeneca","headline":"AstraZeneca sharpens focus on main therapy areas through agreement with gastroenterology specialist Tillotts Pharma for ","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_2":1,"marketed":3},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}